These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 30982983)
41. Ligand binding reduces SUMOylation of the peroxisome proliferator-activated receptor γ (PPARγ) activation function 1 (AF1) domain. Diezko R; Suske G PLoS One; 2013; 8(6):e66947. PubMed ID: 23826177 [TBL] [Abstract][Full Text] [Related]
42. The Contribution of EDF1 to PPARγ Transcriptional Activation in VEGF-Treated Human Endothelial Cells. Cazzaniga A; Locatelli L; Castiglioni S; Maier J Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933613 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of JAK2/STAT3-mediated VEGF upregulation under high glucose conditions by PEDF through a mitochondrial ROS pathway in vitro. Zheng Z; Chen H; Zhao H; Liu K; Luo D; Chen Y; Chen Y; Yang X; Gu Q; Xu X Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):64-71. PubMed ID: 19696171 [TBL] [Abstract][Full Text] [Related]
44. PPARγ affects nitric oxide in human umbilical vein endothelial cells exposed to Porphyromonas gingivalis. Li P; Zhang D; Wan M; Liu J Arch Oral Biol; 2016 Aug; 68():116-22. PubMed ID: 27131027 [TBL] [Abstract][Full Text] [Related]
45. Ampelopsin Improves Insulin Resistance by Activating PPARγ and Subsequently Up-Regulating FGF21-AMPK Signaling Pathway. Zhou Y; Wu Y; Qin Y; Liu L; Wan J; Zou L; Zhang Q; Zhu J; Mi M PLoS One; 2016; 11(7):e0159191. PubMed ID: 27391974 [TBL] [Abstract][Full Text] [Related]
46. SUMOylation of SMAD4 by PIAS1 in Conjunction with Vimentin Upregulation Promotes Migration Potential in Non-Small Cell Lung Cancer. Wu C; Zhu X; Dai Q; Chu Z; Yang S; Dong Z Front Biosci (Landmark Ed); 2023 Aug; 28(8):192. PubMed ID: 37664931 [TBL] [Abstract][Full Text] [Related]
47. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells. Kaplan J; Cook JA; O'Connor M; Zingarelli B Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259 [TBL] [Abstract][Full Text] [Related]
48. PIAS1 mediates TGFbeta-induced SM alpha-actin gene expression through inhibition of KLF4 function-expression by protein sumoylation. Kawai-Kowase K; Ohshima T; Matsui H; Tanaka T; Shimizu T; Iso T; Arai M; Owens GK; Kurabayashi M Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):99-106. PubMed ID: 18927467 [TBL] [Abstract][Full Text] [Related]
49. SUMOylation of PCNA by PIAS1 and PIAS4 promotes template switch in the chicken and human B cell lines. Mohiuddin M; Evans TJ; Rahman MM; Keka IS; Tsuda M; Sasanuma H; Takeda S Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12793-12798. PubMed ID: 30487218 [TBL] [Abstract][Full Text] [Related]
50. Rhizoma Dioscoreae Nipponicae polysaccharides protect HUVECs from H2O2-induced injury by regulating PPARγ factor and the NADPH oxidase/ROS-NF-κB signal pathway. Jin Y; Liu K; Peng J; Wang C; Kang L; Chang N; Sun H Toxicol Lett; 2015 Jan; 232(1):149-58. PubMed ID: 25305479 [TBL] [Abstract][Full Text] [Related]
51. Kakkalide ameliorates endothelial insulin resistance by suppressing reactive oxygen species-associated inflammation. Zhang D; Gao X; Wang Q; Qin M; Liu K; Huang F; Liu B J Diabetes; 2013 Mar; 5(1):13-24. PubMed ID: 23190749 [TBL] [Abstract][Full Text] [Related]
52. The role of PPARγ in intermittent hypoxia-related human umbilical vein endothelial cell injury. Ning-Fang L; Yong-Xu J; Jia C; Cai-Yun W; Jie-Feng H; Qi-Chang L Sleep Breath; 2023 Jun; 27(3):1155-1164. PubMed ID: 35943692 [TBL] [Abstract][Full Text] [Related]
53. Pro-inflammatory Macrophages suppress PPARγ activity in Adipocytes via S-nitrosylation. Yin R; Fang L; Li Y; Xue P; Li Y; Guan Y; Chang Y; Chen C; Wang N Free Radic Biol Med; 2015 Dec; 89():895-905. PubMed ID: 26475041 [TBL] [Abstract][Full Text] [Related]
54. Peroxisome proliferator activated receptor gamma agonists suppress TNFalpha-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species. Jung Y; Song S; Choi C Immunol Lett; 2008 Apr; 117(1):63-9. PubMed ID: 18206249 [TBL] [Abstract][Full Text] [Related]
55. Effect of aging on the expression of peroxisome proliferator-activated receptor gamma and the possible relation to insulin resistance. Ye P; Zhang XJ; Wang ZJ; Zhang C Gerontology; 2006; 52(2):69-75. PubMed ID: 16508313 [TBL] [Abstract][Full Text] [Related]
57. Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. Ghisletti S; Huang W; Ogawa S; Pascual G; Lin ME; Willson TM; Rosenfeld MG; Glass CK Mol Cell; 2007 Jan; 25(1):57-70. PubMed ID: 17218271 [TBL] [Abstract][Full Text] [Related]
58. PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase. Verrier E; Wang L; Wadham C; Albanese N; Hahn C; Gamble JR; Chatterjee VK; Vadas MA; Xia P Circ Res; 2004 Jun; 94(11):1515-22. PubMed ID: 15117825 [TBL] [Abstract][Full Text] [Related]
59. Phlorizin Exerts Direct Protective Effects on Palmitic Acid (PA)-Induced Endothelial Dysfunction by Activating the PI3K/AKT/eNOS Signaling Pathway and Increasing the Levels of Nitric Oxide (NO). Li CY; Wang LX; Dong SS; Hong Y; Zhou XH; Zheng WW; Zheng C Med Sci Monit Basic Res; 2018 Jan; 24():1-9. PubMed ID: 29307883 [TBL] [Abstract][Full Text] [Related]
60. Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging. Scalera F; Martens-Lobenhoffer J; Bukowska A; Lendeckel U; Täger M; Bode-Böger SM Hypertension; 2008 Mar; 51(3):696-703. PubMed ID: 18250362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]